PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1991 November; 84(11): 672–674.
PMCID: PMC1295473

Which ancillary properties of beta-adrenoceptor blocking drugs influence their therapeutic or adverse effects?: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (579K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • al-Sereiti MR, Edeki T, Lledo P, Turner P. The effects of timolol on intraocular pressure and exercise heart rate in poor and extensive debrisoquine metabolizers. Int J Clin Pharmacol Res. 1990;10(6):339–345. [PubMed]
  • Nadelmann J, Frishman WH. Clinical use of beta-adrenoceptor blockade in systemic hypertension. Drugs. 1990 Jun;39(6):862–876. [PubMed]
  • Quyyumi AA, Wright C, Mockus L, Fox KM. Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol. Br Med J (Clin Res Ed) 1984 Oct 13;289(6450):951–953. [PMC free article] [PubMed]
  • Walden RJ, Tomlinson B, Graham B, Liu JB, Prichard BN. Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers. Br J Clin Pharmacol. 1990 Oct;30(4):557–565. [PMC free article] [PubMed]
  • Wilhelmsen L. Practical guidelines for drug therapy after myocardial infarction. Drugs. 1989 Dec;38(6):1000–1007. [PubMed]
  • Vaughan Williams EM. Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial. J Clin Pharmacol. 1991 Feb;31(2):123–135. [PubMed]
  • Poynard T, Calès P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med. 1991 May 30;324(22):1532–1538. [PubMed]
  • Turner P. Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in man. Postgrad Med J. 1989 Jan;65(759):1–6. [PMC free article] [PubMed]
  • Andersson KE, Vinge E. Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs. 1990 Mar;39(3):355–373. [PubMed]
  • Feely J, Peden N. Use of beta-adrenoceptor blocking drugs in hyperthyroidism. Drugs. 1984 May;27(5):425–446. [PubMed]
  • Novack GD. Ophthalmic beta-blockers since timolol. Surv Ophthalmol. 1987 Mar-Apr;31(5):307–327. [PubMed]
  • Turner P. Recent observations on drugs and human fertility. Postgrad Med J. 1988 Aug;64(754):578–580. [PMC free article] [PubMed]
  • Connacher AA, Lakie M, Powers N, Elton RA, Walsh EG, Jung RT. Tremor and the anti-obesity drug BRL 26830A. Br J Clin Pharmacol. 1990 Oct;30(4):613–615. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press